APA (7th ed.) Citation

Suárez-García, I., Moreno, C., Ruiz-Algueró, M., Pérez-Elías, M. J., Navarro, M., Díez Martínez, M., . . . Iribarren, J. A. (2020). Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study. AIDS Research & Therapy, 17(1), 1. https://doi.org/10.1186/s12981-020-00302-2

Chicago Style (17th ed.) Citation

Suárez-García, Inés, et al. "Effectiveness of the Combination Elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) Plus Darunavir Among Treatment-experienced Patients in Clinical Practice: A Multicentre Cohort Study." AIDS Research & Therapy 17, no. 1 (2020): 1. https://doi.org/10.1186/s12981-020-00302-2.

MLA (9th ed.) Citation

Suárez-García, Inés, et al. "Effectiveness of the Combination Elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) Plus Darunavir Among Treatment-experienced Patients in Clinical Practice: A Multicentre Cohort Study." AIDS Research & Therapy, vol. 17, no. 1, 2020, p. 1, https://doi.org/10.1186/s12981-020-00302-2.